Page last updated: 2024-09-03
astilbin and Colitis
astilbin has been researched along with Colitis in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Deng, B; Ding, Y; Gong, W; Han, S; Jia, X; Lin, Z; Lu, G; Wen, J; Wu, K; Xiao, W; Xu, Y; Zhang, Y | 1 |
| Deng, B; Ding, Y; Gong, W; Liang, Y; Qiao, A; Wu, K; Xiao, W | 1 |
Other Studies
2 other study(ies) available for astilbin and Colitis
| Article | Year |
|---|---|
Astilbin promotes the induction of regulatory NK1.1
Topics: Animals; Anti-Inflammatory Agents; Colitis; Extracellular Signal-Regulated MAP Kinases; Female; Flavonols; Humans; Injections, Intraperitoneal; Interleukin-10; Mice; Mice, Inbred C57BL; NK Cell Lectin-Like Receptor Subfamily K; Phosphatidylinositol 3-Kinases; Signal Transduction; Sodium Dodecyl Sulfate; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1 | 2020 |
Induction of TGF-β and IL-10 production in dendritic cells using astilbin to inhibit dextran sulfate sodium-induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Dendritic Cells; Dextran Sulfate; Flavonols; Interleukin-10; Mice; Mice, Inbred C57BL; Transforming Growth Factor beta; Treatment Outcome | 2014 |